Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2004Androgen receptor signaling: mechanism of interleukin-6 inhibitionJia, L.; Choong, C.; Ricciardelli, C.; Kim, J.; Tilley, W.; Coetzee, G.
2019A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancerWarren, A.; Massie, C.; Watt, K.; Luko, K.; Orafidiya, F.; Selth, L.; Mohammed, H.; Chohan, B.; Menon, S.; Baridi, A.; Zhao, W.; Escriu, C.; Pungsrinont, T.; D Santos, C.; Yang, X.; Taylor, C.; Qureshi, A.; Zecchini, V.; Shaw, G.; Dehm, S.; et al.
2017The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancerTran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
2016Computational reconstruction of NFκB pathway interaction mechanisms during prostate cancerBörnigen, D.; Tyekucheva, S.; Wang, X.; Rider, J.R.; Lee, G.S.; Mucci, L.A.; Sweeney, C.; Huttenhower, C.; Przytycka, T.M.
2023Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblastsWu, Y.; Clark, K.C.; Niranjan, B.; Chüeh, A.C.; Horvath, L.G.; Taylor, R.A.; Daly, R.J.
2009A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in ChromatinNeed, E.; Scher, H.; Peters, A.; Moore, N.; Cheong, A.; Ryan, C.; Wittert, G.; Marshall, V.; Tilley, W.; Buchanan, G.
2011Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progressionWang, Q.; Bailey, C.; Ng, C.; Tiffen, J.; Thoeng, A.; Minhas, V.; Lehman, M.; Hendy, S.; Buchanan, G.; Nelson, C.; Rasko, J.
2014Altered endosome biogenesis in prostate cancer has biomarker potentialJohnson, I.; Parkinson-Lawrence, E.; Shandala, T.; Weigert, R.; Butler, L.; Brooks, D.
2015Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activityWang, X.; Huang, Y.; Christie, A.; Bowden, M.; Lee, G.; Kantoff, P.; Sweeney, C.